UNSPSC 51334005: Tiospirone hydrochloride

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C24H32N4O2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 45Q1DF53NN, chemically known as 8-azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)-, monohydrochloride but more generally known as tiospirone hydrochloride, which bears US NIH Compound Identifier 55751. Most nations, for tariff and trade purposes, schedule tiospirone hydrochloride under HS 29349990 and SITC 51579.

As of Q4 2014, TIOSPIRONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tiospirone hydrochloride bears US NLM identifiers UMLS ID C2348793 and NCI Concept Code C72869. SMILES: C1CCC2C(C1)C(NS2)N3CCN(CC3)CCCCN4C(=O)CC5(CCCC5)CC4=O.CL.

UNSPSC 51334005 Tiospirone hydrochloride is a Commodity code that in practice captures state and local procurement of specialized pharmaceuticals and controlled substances for public health and harm-reduction initiatives. The recent opportunities tagged under this code show state and local governments buying naloxone (opioid reversal agents), generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles, and exploring direct-to-manufacturer prescription fulfillment models. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving participating state and local facilities across multiple states including Oregon). Work ranges from tactical procurements of specific harm-reduction supplies with defined annual unit requirements to strategic market research into alternative pharmaceutical supply models outside traditional pharmacy benefit manager and group purchasing organization channels.

The most recent activity spans Florida, Texas, and Minnesota, with the Minnesota cooperative representing a broader multistate footprint. The Seminole County Health Department released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building, with responses due July 26, 2023 (note: date anomaly in source). The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, establishing multiple contracts for generic pharmaceuticals and OTC products, with proposals due March 26, 2026, and award effectiveness July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program, reflecting early-stage exploration of alternative supply models rather than formal competitive bidding.